Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Chimeric Antigen Receptor T Cells Targeting Glypican-3

NCT03884751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China
  • Renji Hospital Shang Hai Jiaotong Unversity of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

NCT00101972

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +80 more
Locations
  • Premiere Oncology Santa Monica, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

NCT02493751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Scottsdale Healthcare Hospitals d/b/a HonorHealth Scottsdale, Arizona, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

NCT03538717

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Sant Pau i Santa Tecla Tarragona, Barcelona, Spain
  • Hospital Universitario Mutua Terrassa Terrassa, Barcelona, Spain
View all 40 locations
View Trial Details
Completed

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT02728258

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

NCT02224456

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Nanjing, Jiangsu, China
View all 19 locations
View Trial Details

Related conditions